Q2 FY27 earnings call · November 16, 2026

EID Parry Q2 FY27 Earnings Call: India Likely to Import Sugar in FY27, FY28 Crop Seen 10% Lower (EIDPARRY)

Cofacto ResearchPublished November 16, 20267 min read
Listen to the earnings call
Quick summary

EID Parry (India) Ltd held its Q2 FY27 earnings call on November 13, 2026. Here's a quick read of what management said — performance, strategy, and the outlook ahead.

Stronger Sugar Realizations Offset Softer Cogeneration & Distillery Pricing

  • Sugar revenue of Rs.486 Cr in Q2 FY 2026-2027 — up from Rs.368 Cr in Q2 FY 2025-2026, driven by higher sales volumes (84,000 MT vs 73,000 MT) and higher realizations (Rs.45.11/kg vs Rs.40.67/kg).
  • Crushing ran 66 days in Q2 FY 2026-2027 — versus 48 days in Q2 FY 2025-2026, with cane crushed of 4.03 lakh MT (vs 3.66 lakh MT); recovery dipped to 7.86% from 7.97%.
  • Cane landed cost rose to Rs.3,798/MT — from Rs.3,620/MT YoY; all cane FRP was paid on time.
  • Distillery revenue of Rs.305 Cr — versus Rs.291 Cr YoY, but average realization fell to Rs.63.99/liter from Rs.67.55/liter; production declined to 307 lakh liters from 392 lakh liters.
  • Cogeneration revenue of Rs.17.67 Cr — up from Rs.11.94 Cr on higher generation (385 lakh units vs 307 lakh units), though realized tariff fell to Rs.3.73/unit from Rs.4.04/unit.
  • CPG turnover declined to Rs.120 Cr — from Rs.165 Cr YoY on lower bulk dal and white sugar sales, but margins were stronger on higher realization and value-added share rising from 16% to 28%.

Tightening Global Balance, Government Intervention Capped Domestic Prices

  • Global sugar market expected to flip to a ~0.2 million MT deficit in FY 2026-2027 — from a ~1.1 million MT surplus in FY 2025-2026, with production of ~180 million MT against consumption of ~180.4 million MT.
  • White sugar rose from ~$467/ton in July to $518/ton in September — and raw sugar from ~14.8 to 17.9 cents/lb during Q2 FY 2026-2027, on a tightening outlook and lower expected Center-South Brazilian production.
  • Brazil's Center-South output revised down to ~38–38.4 million MT for the 2026-27 season — with more cane directed to ethanol; the CEO said Brazil's export availability and Asian import demand will remain key price determinants.
  • India's FY 2025-2026 balance sheet — per the CEO: gross production 31 million MT, ethanol diversion 3.1 million MT, consumption 28.5 million MT, exports 0.8 million MT, closing stock 3.7 million MT.
  • Government interventions moderated ex-mill prices late in Q2 FY 2026-2027 — including duty-free raw sugar imports, tighter dealer stock limits, and more frequent quota allocations, after a subpar southwest monsoon, lower inventories and seasonal demand lifted prices.
  • CEO said India will quite likely need to import sugar in FY 2026-2027 — to bridge the gap, with a shorter season and lower yields in Karnataka and Maharashtra; fresh planting needs close monitoring given lower water availability.
  • A government-constituted expert committee is examining farmer demands — following agitations in Karnataka and Maharashtra; the company is hopeful it leads to "a fair, formulaic, and uniformly applicable policy framework binding on all stakeholders."

El Niño-Driven Shortfall Weighs on FY 2027-2028 Crop

  • Karnataka season started 8–10 days late in FY 2026-2027 — and is expected to be 10–15 days shorter, attributed by management to crop availability and water levels in an El Niño-impacted year, not sowing.
  • Sowing could be reduced by an estimated 8–10% — depending on dam water levels, which would affect FY 2027-2028.
  • EID Parry estimates its FY 2027-2028 crop will be about 10% lower — management said it is too early to comment on the national crop and industry bodies' estimates should be awaited.
  • Cane price in parts of northern Karnataka is around Rs.3,800 for FY 2026-2027 — still evolving after farmer agitations; the formula from about two weeks earlier may no longer apply.
  • FRP in North Karnataka averages roughly Rs.3,300–3,400 — per the CEO, and mills are having to pay significantly above FRP; a formulaic, binding framework is being discussed in government-led committee meetings.
  • Tamil Nadu cane volumes are trending 8–10% higher in FY 2026-2027 — per the CEO; Karnataka remains the highest-margin region, and Tamil Nadu's higher cost of production means the improvement may not substantially change the overall margin profile.

14–15 Crore Litre Alcohol Volume Guidance; Mix Shifting Toward ENA

  • Alcohol volumes (ENA plus ethanol) guided at ~14–15 crore liters for FY 2026-2027 — and in subsequent years, largely molasses-based, with grain-based output continuing from the company's 120 KLPV grain facility.
  • FY 2027-2028 ethanol volume is yet to be determined — with some volumes expected to shift toward ENA, as seen in the first two quarters of FY 2026-2027.
  • Government's allocation formula gives roughly 35–40% of maize ethanol volumes — based on the first bidding round; allocations should stabilise over the next couple of quarters.
  • No capex or inorganic plans in sugar and biofuel segments — per the CEO, with the focus on running those operations effectively.

Recalibration Gaining Traction; Consumer Break-Even Targeted for FY 2027-2028

  • Consumer break-even is being looked at for FY 2027-2028 — as guided previously, per the CEO; the segment stays in investment mode until then.
  • Analyst Gautam (Nellanda Securities) flagged a Rs.500 Cr FY 2026-27 consumer revenue target — cited in a TV interview, followed by 20–25% growth in FY 2027-28; ~Rs.200 Cr was done in H1 FY 2026-27, leaving roughly Rs.300 Cr for H2 FY 2026-27.
  • Contribution margin 1 has "significantly moved up" — two quarters into the recalibration; turnover declined because low-margin bulk pulses and bulk white sugar categories were exited.
  • Distribution expansion is a key FY 2026-27 consumer growth driver — with new jaggery products expected to launch toward the end of Q3 FY 2026-27; the product line needs expansion for FY 2027-28 and is being strategized.
  • Nutraceuticals (via wholly owned US subsidiary Valensa International) had a strong H1 and Q2 FY 2026-2027 — Indian turnover of Rs.10.26 Cr (vs Rs.7.6 Cr) and consolidated turnover of Rs.70 Cr (vs Rs.61 Cr); growth led by prostate health, joint health, and immunity and greens, plus a newer derm and hair care launch.
  • Capital needs in consumer are opex, not capex — (A&SP, manpower, product development); no capital allocation plans for nutraceuticals. Refinery asset monetization is meant to strengthen the core and standalone balance sheet, with future capital allocation likely in consumer FMCG; no timeline given, and no buyback discussion at this point.

"Par Year" Framing for FY 2026-2027; PSRIPL Closure Nearing Final Duty Payment

  • CEO estimated FY 2026-2027 combined sugar, distillery and Cogent performance will be a "par year" versus FY 2025-2026 — the CFO said it is too early to comment on guidance, with an update to come at Q3 FY 2026-2027.
  • Sugar contracting strategy mirrors spot — the company avoided longer-term contracts over the last 6 months due to price volatility and has completed ~96–97% of long-term contracts; most prime-customer contracts now run about 15–24 days.
  • PSRIPL (100% subsidiary) closure on track — as of 30 September 2026 all inventories were sold and proceeds realized; the ACZ exit unit received an in-principle exit letter in April and duty computation workings were submitted in June, with the final duty payment expected in Q3 FY 2026-2027.
  • Refinery duty quantum not disclosed — under valuation; the duty liability was already factored in as on 31 March 2026, and the company will revert once the final payment is made.
  • Diversification beyond the sugar cycle remains exploratory — management is not exploring biochemicals; it is exploring the substrate side (green growth media and better bagasse monetization, already commercialized), expected to lead to "stronger businesses as we go forward" (period unspecified).
  • Asset monetization awaits SEZ completion and environmental clearance — no timeline given.

Ask about this

Ask Cofacto a question about this call. Answers cite filings and company data.

Companies on this page

Related

Share on X · LinkedIn · WhatsApp

Disclaimer: This earnings call summary is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.